New drug combination holds unusually positive results for HPV-negative patients with advanced head and neck cancer

A new combination drug treatment has shown promising results in patients with pan-refractory, recurrent/metastatic head and neck cancer, according to a study published today in the Journal of Clinical Oncology.

Leave A Comment

Your email address will not be published. Required fields are marked *